Skip to main content

Table 5 Acquired infectious complications

From: Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study

 

GROUP A

GROUP B

GROUP C

p value

(n = 52)

(n = 53)

(n = 52)

Number of infected patients

18/52 (34.6 %)

23/53 (43.4 %)

23/52 (44.2 %)

0.54

Odds ratio

1.4 (0.6–3.1)a

1.03 (0.4–2.2)c

1.4 (0.6–3.3)b

Infectious complication incidence rate / % treatment days

22/546 (4.03)

24/470 (5.11)

24/505 (4.75)

0.51

Catheter-related bloodstream infection

1/52 (1.92 %)

1/53 (1.89 %)

2/52 (3.85 %)

0.53

Primary bloodstream infection

3/52 (5.77 %)

1/53 (1.89 %)

3/52 (5.77 %)

0.25

UTI

1/52 (1.92 %)

1/53 (1.89 %)

1/52 (1.92 %)

1.00

Tracheobronchitis incidence rate / 1000 ventilator days

7/460 (15.2)*a

10/392 (25.5)

7/424 (16.5)*c

<0.01*

VAP incidence rate / 1000 ventilator days

8/460 (17.3)*a

10/392 (25.5)

6/424 (14.1)*c

<0.05*a

 < 0.01*c

  1. Values are provided as percentages (%) and incidence rate. Asterisks indicate statistical significance
  2. UTI urinary tract infection, VAP ventilator-associated pneumonia
  3. aDifference group A vs. group B
  4. bDifference group A vs. group C
  5. cDifference group B vs. group C